Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis.
Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis.
Polymyositis associated with interstitial pulmonary fibrosis and glomerulonephritis. A report of two autopsy cases.
Management of interstitial lung disease associated with connective tissue disease.
Mathai SC, Danoff SK.
BMJ. 2016 Feb 24;352:h6819. doi: 10.1136/bmj.h6819.
Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management.
Yoo H, Hino T, Hwang J, Franks TJ, Han J, Im Y, Lee HY, Chung MP, Hatabu H, Lee KS.
Eur J Radiol Open. 2022 Apr 7;9:100419. doi: 10.1016/j.ejro.2022.100419. eCollection 2022.
Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay.
Palmucci S, Galioto F, Fazio G, Ferlito A, Cancemi G, Di Mari A, Sambataro G, Sambataro D, Zanframundo G, Mauro LA, Foti PV, Vancheri C, Basile A.
Insights Imaging. 2022 Jun 29;13(1):108. doi: 10.1186/s13244-022-01243-2.
Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management.
Yoo H, Hino T, Han J, Franks TJ, Im Y, Hatabu H, Chung MP, Lee KS.
Eur J Radiol Open. 2020 Dec 16;8:100311. doi: 10.1016/j.ejro.2020.100311. eCollection 2021.
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Barnes H, Holland AE, Westall GP, Goh NS, Glaspole IN.
Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2.
Idiopathic pulmonary fibrosis.
Meltzer EB, Noble PW.
Orphanet J Rare Dis. 2008 Mar 26;3:8. doi: 10.1186/1750-1172-3-8.
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort.
Zanatta E, Cocconcelli E, Castelli G, Giraudo C, Fraia AS, De Zorzi E, Gatto M, Ienna L, Treppo E, Malandrino D, Cereser L, Emmi G, Giannelli F, Bellani S, Martini A, Moccaldi B, Ghirardello A, Avouac J, Quartuccio L, Allanore Y, Doria A, Spagnolo P, Balestro E, Iaccarino L.
RMD Open. 2023 Aug;9(3):e003121. doi: 10.1136/rmdopen-2023-003121.
Anti-Jo-1 antibodies.
Zampieri S, Ghirardello A, Iaccarino L, Tarricone E, Gambari PF, Doria A.
Autoimmunity. 2005 Feb;38(1):73-8. doi: 10.1080/08916930400022640.
Mixed connective tissue disease.
Gunnarsson R, Hetlevik SO, Lilleby V, Molberg Ø.
Best Pract Res Clin Rheumatol. 2016 Feb;30(1):95-111. doi: 10.1016/j.berh.2016.03.002. Epub 2016 Apr 12.
Immunosuppressive drug therapy.
McCune WJ, Vallance DK, Lynch JP 3rd.
Curr Opin Rheumatol. 1994 May;6(3):262-72. doi: 10.1097/00002281-199405000-00004.
